Guys
Of course the shorts want to promote the other thread but really the prospects of an upgrade are much closer to market developments than a downgrade. I saw an interview with the head of a major competitor and they regard A2 as the market leader in the premium Infant Formula space in China and they cannot see any competitor threatening A2's, premium market leader position in the near future. All the competitors price their product off A2's China label product and the latest data suggests sales volumes and pricing are rapidly improving, according to Hong Kong Analysts which I cannot reveal. So an upgrade is very likely.
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.34 |
Change
0.120(1.66%) |
Mkt cap ! $5.314B | |||
| Open | High | Low | Value | Volume |
| $7.20 | $7.34 | $7.13 | $17.16M | 2.358M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1360 | $7.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.34 | 39998 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |